Position in HIMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,801,590
+$33,248,756 QoQ
Shares Held
1,032,639
+739.8% QoQ
Ownership
0.443%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 507 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in HIMS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,801,590 | 1,032,639 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,552,834 | 122,969 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $22,450,403 | 691,420 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $41,715,627 | 735,466 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,536,119 | 712,861 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,735,515 | 464,823 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,671,404 | 441,332 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $21,683,930 | 1,177,195 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $28,263,070 | 1,399,855 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $27,238,011 | 1,760,699 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $16,105,091 | 1,809,561 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $11,354,775 | 1,805,211 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,963,398 | 1,804,617 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,258,566 | 1,739,775 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,725,414 | 1,829,238 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $10,237,413 | 1,834,662 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,263,127 | 1,824,090 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $10,520,673 | 1,973,860 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,914,942 | 1,971,747 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,868,479 | 1,971,947 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $35,550,862 | 3,264,542 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $57,201,042 | 4,323,586 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||